Herceptin®: Breaking New Ground

This publication has 9 references indexed in Scilit:

• The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
  The International Journal of Cell Cloning, 1998
• Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies
  Cancer Immunology, Immunotherapy, 1993
• Humanization of an anti-p185HER2 antibody for human cancer therapy.
  Proceedings of the National Academy of Sciences, 1992
• Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
  Cell, 1989
• p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
  Molecular and Cellular Biology, 1989
• Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
  Cell, 1988
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF Receptor
  Science, 1985
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
  Nature, 1984